Earnings Feed
Start Free
Home/Insiders/JEFFS ROGER
JR
SEC Insider//CIK 0001231615

JEFFS ROGER

CIK 00012316157 companiesNEW YORK, NY
SEC Profile

Transactions

50

Companies

7

Filings

9

CIK

0001231615

Recent Transactions

50 trades
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2026-06-11$249.12/sh−286→ 58,367 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2026-06-10$246.18/sh−286→ 58,653 total
  • Exercise/Conversion
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2026-06-08+1,429→ 58,939 total
  • Exercise/Conversion
    Axsome Therapeutics, Inc.$AXSM

    Restricted Stock Units

    2026-06-08−1,429→ 0 total
  • Award
    Axsome Therapeutics, Inc.$AXSM

    Restricted Stock Units

    2026-06-05+1,721→ 1,721 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-27$62.18/sh−6,428→ 1,041,667 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-26$60.38/sh−25,000→ 1,048,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-22$61.52/sh−25,000→ 1,073,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-21$61.13/sh−25,000→ 1,098,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-20$61.30/sh−25,000→ 1,123,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-19$58.65/sh−25,000→ 1,148,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-18$56.77/sh−25,000→ 1,173,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-15$57.04/sh−25,000→ 1,198,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-14$58.62/sh−25,000→ 1,223,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-13$56.29/sh−25,000→ 1,248,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-12$54.04/sh−25,000→ 1,273,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-11$41.50/sh−25,000→ 1,298,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-08$42.14/sh−25,000→ 1,323,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-07$42.09/sh−25,000→ 1,348,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-06$40.78/sh−25,000→ 1,373,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-05-05$40.10/sh−25,000→ 1,398,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-17$40.60/sh−18,839→ 1,423,095 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-16$40.31/sh−25,000→ 1,441,934 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-15$40.14/sh−25,000→ 1,466,934 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-14$40.00/sh−3,300→ 1,491,934 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-13$38.37/sh−32,744→ 1,137,599 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-04-10+13,834→ 1,156,010 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-04-10+14,333→ 1,170,343 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-10$40.12/sh−21,433→ 1,495,234 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-04-10−13,834→ 96,835 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-04-10−14,333→ 157,662 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-04-09$40.12/sh−25,000→ 1,516,667 total
  • Award
    Liquidia Corp$LQDA

    Common Stock

    2026-01-16+115,344→ 1,152,872 total
  • Award
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-16+173,016→ 173,016 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2026-01-12$37.43/sh−66,610→ 1,037,528 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-01-09+13,833→ 1,046,806 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2026-01-09+57,332→ 1,104,138 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-09−13,833→ 110,669 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2026-01-09−57,332→ 171,995 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-10-13$23.41/sh−20,261→ 1,032,973 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Common Stock

    2025-10-10+13,834→ 1,053,234 total
  • Exercise/Conversion
    Liquidia Corp$LQDA

    Performance Stock Units

    2025-10-10−13,834→ 124,502 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-09-02$123.68/sh−13,464→ 57,510 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-08-29$121.27/sh−20,000→ 70,974 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-08-28$121.60/sh−20,000→ 90,974 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-08-27$122.30/sh−20,000→ 110,974 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-08-26$120.03/sh−20,000→ 130,974 total
  • Sale
    Axsome Therapeutics, Inc.$AXSM

    Common Stock

    2025-08-22$120.08/sh−16,694→ 150,974 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-07-14$14.28/sh−20,252→ 1,038,560 total
  • Sale
    Liquidia Corp$LQDA

    Common Stock

    2025-07-14$14.28/sh−20,252→ 1,038,560 total

Companies

7

Recent Filings

9

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007

View on SEC.gov